![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Janssen Pharmaceutica Nv Beerse Be, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Haloperidol, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1998-076 - Rev 09
This Chemical Type CEP, issued on June 05, 2014, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 616 associated with this CEP further emphasizes